REFERENCES
- World Cancer Research Fund, American Institute for Cancer Research: Food, Nutrition, Physical Activity, and the Prevention of Cancer: a global perspective. World Cancer Research Fund, American Institute for Cancer Research: Washington, DC, 2007.
- Cancer Registry of Norway: Cancer in Norway 2010: Cancer incidence, Mortality, Survival and Prevalence in Norway. Cancer Registry of Norway: Oslo, Norway, 2012.
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al.: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127, 2893–2917, 2010.
- Gronberg H: Prostate cancer epidemiology. Lancet 361, 859–864, 2003.
- Lee J, Demissie K, Lu SE, and Rhoads GG: Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea. Cancer Control 14, 78–85, 2007.
- Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, et al.: Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 87, 1767–1776, 1995.
- Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, and Willett WC: A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 94, 391–398, 2002.
- Key TJ, Appleby PN, Allen NE, Travis RC, Roddam AW, et al.: Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. Am J Clin Nutr 86, 672–681, 2007.
- Kirsh VA, Mayne ST, Peters U, Chatterjee N, Leitzmann MF, et al.: A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15, 92–98, 2006.
- Di MP, Kaiser S, and Sies H: Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274, 532–538, 1989.
- Wertz K, Siler U, and Goralczyk R: Lycopene: modes of action to promote prostate health. Arch Biochem Biophys 430, 127–134, 2004.
- Boileau TW, Liao Z, Kim S, Lemeshow S, Erdman JW, Jr., et al.: Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets. J Natl Cancer Inst 95, 1578–1586, 2003.
- Canene-Adams K, Lindshield BL, Wang S, Jeffery EH, Clinton SK, et al.: Combinations of tomato and broccoli enhance antitumor activity in dunning r3327-h prostate adenocarcinomas. Cancer Res 67, 836–843, 2007.
- Pannellini T, Iezzi M, Liberatore M, Sabatini F, Iacobelli S, et al.: A dietary tomato supplement prevents prostate cancer in TRAMP mice. Cancer Prev Res (Phila) 3, 1284–1291, 2010.
- De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, et al.: Inflammation in prostate carcinogenesis. Nat Rev Cancer 7, 256–269, 2007.
- Karin M, Yamamoto Y, and Wang QM: The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov 3, 17–26, 2004.
- Karin M: NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 1, a000141, 2009.
- Karin M: Nuclear factor-kappaB in cancer development and progression. Nature 441, 431–436, 2006.
- Karin M, Cao Y, Greten FR, and Li ZW: NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2, 301–310, 2002.
- Neurath MF, Becker C, and Barbulescu K: Role of NF-kappaB in immune and inflammatory responses in the gut. Gut 43, 856–860, 1998.
- Valen G, Yan ZQ, and Hansson GK: Nuclear factor kappa-B and the heart. J Am Coll Cardiol 38, 307–314, 2001.
- Mattson MP and Camandola S: NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 107, 247–254, 2001.
- Shukla S, MacLennan GT, Fu P, Patel J, Marengo SR, et al.: Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Neoplasia 6, 390–400, 2004.
- Gasparian AV, Yao YJ, Kowalczyk D, Lyakh LA, Karseladze A, et al.: The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells. J Cell Sci 115, 141–151, 2002.
- Chen CD and Sawyers CL: NF-kappa B activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer. Mol Cell Biol 22, 2862–2870, 2002.
- Lessard L, Mes-Masson AM, Lamarre L, Wall L, Lattouf JB, et al.: NF-kappa B nuclear localization and its prognostic significance in prostate cancer. BJU Int 91, 417–420, 2003.
- Grivennikov SI, Greten FR, and Karin M: Immunity, inflammation, and cancer. Cell 140, 883–899, 2010.
- Ammirante M, Luo JL, Grivennikov S, Nedospasov S, and Karin M: B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 464, 302–305, 2010.
- Paur I, Austenaa LM, and Blomhoff R: Extracts of dietary plants are efficient modulators of nuclear factor kappa B. Food Chem Toxicol 46, 1288–1297, 2008.
- Simone RE, Russo M, Catalano A, Monego G, Froehlich K, et al.: Lycopene inhibits NF-kB-mediated IL-8 expression and changes redox and PPARgamma signalling in cigarette smoke-stimulated macrophages. PLoS One 6, e19652, 2011.
- Tuzcu M, Aslan A, Tuzcu Z, Yabas M, Bahcecioglu IH, et al.: Tomato powder impedes the development of azoxymethane-induced colorectal cancer in rats through suppression of COX-2 expression via NF-kappaB and regulating Nrf2/HO-1 pathway. Mol Nutr Food Res 56, 1477–1481, 2012.
- Bastani NE, Kostovski E, Sakhi AK, Karlsen A, Carlsen MH, et al.: Reduced antioxidant defense and increased oxidative stress in spinal cord injured patients. Arch Phys Med Rehabil 93, 2223–2228, 2012.
- Benzie IF and Strain JJ: The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 239, 70–76, 1996.
- Halvorsen BL, Holte K, Myhrstad MC, Barikmo I, Hvattum E, et al.: A systematic screening of total antioxidants in dietary plants. J Nutr 132, 461–471, 2002.
- Venkateswaran V and Klotz LH: Diet and prostate cancer: mechanisms of action and implications for chemoprevention. Nat Rev Urol 7, 442–453, 2010.
- Lee ST, Wong PF, Cheah SC, and Mustafa MR: Alpha-tomatine induces apoptosis and inhibits nuclear factor-kappa B activation on human prostatic adenocarcinoma PC-3 cells. PLoS One 6, e18915, 2011.
- Palozza P, Colangelo M, Simone R, Catalano A, Boninsegna A, et al.: Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines. Carcinogenesis 31, 1813–1821, 2010.
- Ivanov NI, Cowell SP, Brown P, Rennie PS, Guns ES, et al.: Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines. Clin Nutr 26, 252–263, 2007.
- Tang L, Jin T, Zeng X, and Wang JS. Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice. J Nutr 135, 287–290, 2005.
- Goo YA, Li Z, Pajkovic N, Shaffer S, Taylor G, et al.: Systematic investigation of lycopene effects in LNCaP cells by use of novel large-scale proteomic analysis software. Proteomics Clin Appl 1, 513–523, 2007.
- Yang CM, Lu IH, Chen HY, and Hu ML: Lycopene inhibits the proliferation of androgen-dependent human prostate tumor cells through activation of PPARgamma-LXRalpha-ABCA1 pathway. J Nutr Biochem 23, 8–17, 2012.
- Hantz HL, Young LF, and Martin KR. Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells. Exp Biol Med (Maywood) 230, 171–179, 2005.
- Aust O, Ale-Agha N, Zhang L, Wollersen H, Sies H, et al.: Lycopene oxidation product enhances gap junctional communication. Food Chem Toxicol 41, 1399–1407, 2003.
- Owen-Schaub LB: Fas function and tumor progression: use it and lose it. Cancer Cell 2, 95–96, 2002.
- Wurstle ML, Laussmann MA, and Rehm M: The central role of initiator caspase-9 in apoptosis signal transduction and the regulation of its activation and activity on the apoptosome. Exp Cell Res 318, 1213–1220, 2012.
- Harris AL: Hypoxia—a key regulatory factor in tumour growth. Nat Rev Cancer 2, 38–47, 2002.
- Perkins ND: The diverse and complex roles of NF-kappaB subunits in cancer. Nat Rev Cancer 12, 121–132, 2012.
- Rico-Bautista E, Flores-Morales A, and Fernandez-Perez L: Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions. Cytokine Growth Factor Rev 17, 431–439, 2006.
- Luo K, Stroschein SL, Wang W, Chen D, Martens E, et al.: The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev 13, 2196–2206, 1999.
- Vo BT, Cody B, Cao Y, and Khan SA: Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-beta)-induced Smad signaling in prostate cancer cells. Carcinogenesis 33, 2054–2064, 2012.
- Lawrence T and Natoli G: Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 11, 750–761, 2011.
- Sica A and Bronte V: Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 117, 1155–1166, 2007.
- Siegel PM and Massague J: Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 3, 807–821, 2003.
- Konijeti R, Henning S, Moro A, Sheikh A, Elashoff D, et al.: Chemoprevention of prostate cancer with lycopene in the TRAMP model. Prostate 70, 1547–1554, 2010.
- Yang CM, Yen YT, Huang CS, and Hu ML: Growth inhibitory efficacy of lycopene and beta-carotene against androgen-independent prostate tumor cells xenografted in nude mice. Mol Nutr Food Res 55, 606–612, 2011.
- Bunker CH, McDonald AC, Evans RW, de la Rosa N, Boumosleh JM, et al.: A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk. Nutr Cancer 57, 130–137, 2007.
- van Breemen RB, Sharifi R, Viana M, Pajkovic N, Zhu D, et al.: Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: a randomized, controlled trial. Cancer Prev Res (Phila) 4, 711–718, 2011.
- Jones HB and Grendon A: Analysis of mathematical models used in data extrapolation. Clin Toxicol 9, 791–797, 1976.
- Pinkel D: The use of body surface area as a criterion of drug dosage in cancer chemotherapy. Cancer Res 18, 853–856, 1958.
- Lee CM, Boileau AC, Boileau TW, Williams AW, Swanson KS, et al.: Review of animal models in carotenoid research. J Nutr 129, 2271–2277, 1999.
- van Breemen RB, Xu X, Viana MA, Chen L, Stacewicz-Sapuntzakis M, et al.: Liquid chromatography-mass spectrometry of cis- and all-trans-lycopene in human serum and prostate tissue after dietary supplementation with tomato sauce. J Agric Food Chem 50, 2214–2219, 2002.
- Schmitz HH, Poor CL, Wellman RB, and Erdman JW, Jr.: Concentrations of selected carotenoids and vitamin A in human liver, kidney and lung tissue. J Nutr 121, 1613–1621, 1991.
- Freeman VL, Meydani M, Yong S, Pyle J, Wan Y, et al.: Prostatic levels of tocopherols, carotenoids, and retinol in relation to plasma levels and self-reported usual dietary intake. Am J Epidemiol 151, 109–118, 2000.
- Clinton SK, Emenhiser C, Schwartz SJ, Bostwick DG, Williams AW, et al.: Cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 5, 823–833, 1996.
- Moran NE, Erdman JW, Jr., and Clinton SK: Complex interactions between dietary and genetic factors impact lycopene metabolism and distribution. Arch Biochem Biophys 539, 171–180, 2013.
- Gartner C, Stahl W, and Sies H: Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am J Clin Nutr 66, 116–122, 1997.
- Stahl W and Sies H: Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans. J Nutr 122, 2161–2166, 1992.